SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,292,375 | +41.5% | 197,626 | +26.3% | 0.35% | +3.6% |
| Q1 2023 | $6,567,537 | +10.3% | 156,519 | +0.3% | 0.34% | +1.5% |
| Q4 2022 | $5,953,540 | -2.8% | 156,097 | -0.2% | 0.33% | -10.7% |
| Q3 2022 | $6,127,000 | +22.3% | 156,478 | +0.9% | 0.37% | -3.1% |
| Q2 2022 | $5,011,000 | -0.5% | 155,118 | +2.0% | 0.38% | +23.4% |
| Q1 2022 | $5,035,000 | -21.6% | 152,103 | +0.8% | 0.31% | -16.4% |
| Q4 2021 | $6,420,000 | -10.2% | 150,897 | -6.4% | 0.37% | -21.1% |
| Q3 2021 | $7,146,000 | -22.0% | 161,290 | +0.1% | 0.47% | -21.7% |
| Q2 2021 | $9,158,000 | -24.0% | 161,205 | +0.1% | 0.60% | -31.5% |
| Q1 2021 | $12,056,000 | -13.3% | 161,061 | +0.2% | 0.88% | -17.9% |
| Q4 2020 | $13,911,000 | +44.7% | 160,805 | +2.2% | 1.07% | +26.8% |
| Q3 2020 | $9,613,000 | +228.4% | 157,270 | +123.4% | 0.85% | +201.4% |
| Q2 2020 | $2,927,000 | +86.0% | 70,383 | +28.4% | 0.28% | +17.1% |
| Q1 2020 | $1,574,000 | -67.8% | 54,824 | -18.9% | 0.24% | -61.5% |
| Q4 2019 | $4,881,000 | +148.3% | 67,613 | +382.6% | 0.62% | +10.1% |
| Q3 2019 | $1,966,000 | -22.8% | 14,010 | +0.8% | 0.57% | -23.5% |
| Q2 2019 | $2,545,000 | +14.7% | 13,903 | -0.3% | 0.74% | +9.8% |
| Q1 2019 | $2,219,000 | +94.5% | 13,949 | +17.1% | 0.67% | +67.7% |
| Q4 2018 | $1,141,000 | +18.7% | 11,916 | +37.0% | 0.40% | -31.5% |
| Q3 2018 | $961,000 | -29.3% | 8,700 | 0.0% | 0.59% | +24.4% |
| Q2 2018 | $1,360,000 | – | 8,700 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |